Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
Recruiting · NCT05872204 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer | Adult Type Granulosa Cell Tumor; Low Grade Serous Ovarian Carcinoma | Recruiting | Phase 2 | 2026-05-05 | NCT05872204 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
| European Network of Gynaecological Oncological Trial Groups (ENGOT) | 34 |
| Kom Op Tegen Kanker | 20 |
| Universitaire Ziekenhuizen KU Leuven | 262 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Leon Berard | Lyon | France | 1 |
| CHU de Liège | Liège | Belgium | 6 |
| Erasmus Medical Center Rotterdam | Rotterdam | Netherlands | 1 |
| Groupe Hospitalier Diaconesses Croix Saint Simon | Paris | France | 3 |
| Institut Bergonie | Bordeaux | France | 2 |
| Institut De Cancerologie De L'Ouest | Saint-Herblain | France | 1 |
| Institut De Cancerologie Strasbourg Europe | Strasbourg | France | 1 |
| Institut Universitaire Du Cancer Toulouse-Oncopole | Toulouse | France | 1 |
| University Medical Center Groningen | Groningen | Netherlands | 16 |
| University Medical Center Utrecht | Utrecht | Netherlands | 17 |
| UZ Gent | Ghent | Belgium | 36 |
| UZ Leuven | Leuven | Belgium | 70 |